Cargando…
LRP1 expression in colon cancer predicts clinical outcome
LRP1 (low-density lipoprotein receptor-related protein 1), a multifunctional endocytic receptor, has recently been identified as a hub within a biomarker network for multi-cancer clinical outcome prediction. As its role in colon cancer has not yet been characterized, we here investigate the relation...
Autores principales: | Boulagnon-Rombi, Camille, Schneider, Christophe, Leandri, Chloé, Jeanne, Albin, Grybek, Virginie, Bressenot, Aude Marchal, Barbe, Coralie, Marquet, Benjamin, Nasri, Saviz, Coquelet, Christelle, Fichel, Caroline, Bouland, Nicole, Bonnomet, Arnaud, Kianmanesh, Reza, Lebre, Anne-Sophie, Bouché, Olivier, Diebold, Marie-Danièle, Bellon, Georges, Dedieu, Stéphane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823651/ https://www.ncbi.nlm.nih.gov/pubmed/29507659 http://dx.doi.org/10.18632/oncotarget.24225 |
Ejemplares similares
-
Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?
por: Galissier, Thibaut, et al.
Publicado: (2016) -
Targeting Ovarian Carcinoma with TSP-1:CD47 Antagonist TAX2 Activates Anti-Tumor Immunity
por: Jeanne, Albin, et al.
Publicado: (2021) -
Identification of TAX2 peptide as a new unpredicted anti-cancer agent
por: Jeanne, Albin, et al.
Publicado: (2015) -
LRP-1 Matricellular Receptor Involvement in Triple Negative Breast Cancer Tumor Angiogenesis
por: Campion, Océane, et al.
Publicado: (2021) -
Lumican delays melanoma growth in mice and drives tumor molecular assembly as well as response to matrix-targeted TAX2 therapeutic peptide
por: Jeanne, Albin, et al.
Publicado: (2017)